Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DUCTAL CARCINOMA INSITU' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 88 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Markopoulos, C; Kouskos, E; Koufopoulos, K; Kyriakou, V; Gogas, J
      Use of artificial neural networks (computer analysis) in the diagnosis of microcalcifications on mammography

      EUROPEAN JOURNAL OF RADIOLOGY
    2. Sakorafas, GH; Blanchard, K; Sarr, MG; Farley, DR
      Paget's disease of the breast

      CANCER TREATMENT REVIEWS
    3. Beenken, SW; Grizzle, WE; Crowe, DR; Conner, MG; Weiss, HL; Sellers, MT; Krontiras, H; Urist, MM; Bland, KI
      Molecular biomarkers for breast cancer prognosis: Coexpression of c-erbB-2and p53

      ANNALS OF SURGERY
    4. Walker, RA
      The significance of histological determination of HER-2 status in breast cancer

      BREAST
    5. Satake, H; Shimamoto, K; Sawaki, A; Niimi, R; Ando, Y; Ishiguchi, T; Ishigaki, T; Yamakawa, K; Nagasaka, T; Funahashi, H
      Role of ultrasonography in the detection of intraductal spread of breast cancer: correlation with pathologic findings, mammography and MR imaging

      EUROPEAN RADIOLOGY
    6. Stark, A; Hulka, BS; Joens, S; Novotny, D; Thor, AD; Wold, LE; Schell, MJ; Melton, LJ; Liu, ET; Conway, K
      HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    7. Stomper, PC; Budnick, RM; Stewart, CC
      Use of specimen mammography-guided FNA (fine-needle aspirates) for flow cytometric multiple marker analysis and. immunophenotyping in breast cancer

      CYTOMETRY
    8. Stucker, DT; Ikeda, DM; Hartman, AR; George, TI; Nowels, KW; Birdwell, SL; Goffinet, D; Carlson, RW
      New bilateral microcalcifications at mammography in a postlactational woman: Case report

      RADIOLOGY
    9. Cornez, N; Piccart, MJ
      Breast cancer and Herceptin

      BULLETIN DU CANCER
    10. Simmons, RM; Osborne, MP
      The evaluation of high risk and pre-invasive breast lesions and the decision process for follow up and surgical intervention

      SURGICAL ONCOLOGY-OXFORD
    11. Querzoli, P; Albonico, G; Ferretti, S; Rinaldi, R; Magri, E; Nenci, I
      Quantitative immunoprofiles of breast cancer performed by image analysis

      ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
    12. Penault-Llorca, F; Jacquemier, J
      Factors predicting treatment responsiveness, prognosis, or carcinogenetic status : current aspects of ERBB-2 activation in breast cancer

      ANNALES DE PATHOLOGIE
    13. Vakkala, M; Paakko, P; Soini, Y
      Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion

      BRITISH JOURNAL OF CANCER
    14. Johnson, JM; Dalton, RR; Wester, SM; Landercasper, J; Lambert, PJ
      Histological correlation of microcalcifications in breast biopsy specimens

      ARCHIVES OF SURGERY
    15. REVILLION F; BONNETERRE J; PEYRAT JP
      ERBB2 ONCOGENE IN HUMAN BREAST-CANCER AND ITS CLINICAL-SIGNIFICANCE

      European journal of cancer
    16. SHARPE CR
      A DEVELOPMENTAL HYPOTHESIS TO EXPLAIN THE MULTICENTRICITY OF BREAST-CANCER

      CMAJ. Canadian Medical Association journal
    17. ALBONICO G; QUERZOLI P; FERRETTI S; RINALDI R; NENCI I
      BIOLOGICAL PROFILE OF IN-SITU BREAST-CANCER INVESTIGATED BY IMMUNOHISTOCHEMICAL TECHNIQUE

      Cancer detection and prevention
    18. BLICHERTTOFT M; SMOLA MG; CATALIOTTI L; OHIGGINS N
      PRINCIPLES AND GUIDELINES FOR SURGEONS - MANAGEMENT OF SYMPTOMATIC BREAST-CANCER - ON BEHALF OF THE EUROPEAN-SOCIETY OF SURGICAL ONCOLOGY

      Annales chirurgiae et gynaecologiae
    19. LAZZARO G; SHARPLESS S; QING WG; MEHTA RR; DASGUPTA TK; MEHTA R
      STUDY OF NM23 GENE-EXPRESSION IN AN N-METHYL-N-NITROSOUREA TRANSFORMED HUMAN BREAST EPITHELIAL-CELL LINE

      International journal of oncology
    20. BLICHERTTOFT M; SMOLA MG; CATALIOTTI L; OHIGGINS N
      PRINCIPLES AND GUIDELINES FOR SURGEONS - MANAGEMENT OF SYMPTOMATIC BREAST-CANCER

      European journal of surgical oncology
    21. SHACKNEY SE; SHANKEY TV
      COMMON PATTERNS OF GENETIC EVOLUTION IN HUMAN SOLID TUMORS

      Cytometry
    22. DECKER T; RUHNKE M; SCHNEIDER W
      STANDARDIZED PATHOLOGICAL EXAMINATION OF BREAST BIOPSY SPECIMENS

      Der Pathologe
    23. WALKER RA; JONES JL; CHAPPELL S; WALSH T; SHAW JA
      MOLECULAR PATHOLOGY OF BREAST-CANCER AND ITS APPLICATION TO CLINICAL MANAGEMENT

      Cancer metastasis reviews
    24. PERLMUTTER SM; COSMAN PC; GRAY RM; OLSHEN RA; IKEDA D; ADAMS CN; BETTS BJ; WILLIAMS MB; PERLMUTTER KO; LI J; AIYER A; FAJARDO L; BIRDWELL R
      IMAGE QUALITY IN LOSSY COMPRESSED DIGITAL MAMMOGRAMS

      Signal processing
    25. OTMEZGUINE Y; CALITCHI E; COTHIER I; FEUILHADE F; LEBOURGEOIS JP; BARUCH J
      REDUCTION MAMMAPLASTY AND RADIATION-THERAPY CAN ALLOW BREAST-CONSERVATION IN PATIENTS WITH BREAST CANCERS NOT INITIALLY TREATABLE BY TUMORECTOMY

      La Semaine des hopitaux de Paris
    26. LIBERMAN L; LATRENTA LR; VANZEE KJ; MORRIS EA; ABRAMSON AF; DERSHAW DD
      STEREOTAXIC CORE BIOPSY OF CALCIFICATIONS HIGHLY SUGGESTIVE OF MALIGNANCY

      Radiology
    27. NABI HA
      ANTIBODY IMAGING IN BREAST-CANCER

      Seminars in nuclear medicine
    28. ZAVOTSKY J; GARDNER B
      POSTEXCISIONAL RECURRENCE OF CARCINOMA OF THE BREAST

      Journal of the American College of Surgeons
    29. HALYARD MY; GRADO GL; SCHOMBERG PJ; WEAVER AL; GRANT CS; PISANSKY TM
      CONSERVATIVE THERAPY OF BREAST-CANCER - THE MAYO-CLINIC EXPERIENCE

      American journal of clinical oncology
    30. KERLIKOWSKE K; GRADY D; BARCLAY J; SICKLES EA; ERNSTER V
      EFFECT OF AGE, BREAST DENSITY, AND FAMILY HISTORY ON THE SENSITIVITY OF FIRST SCREENING MAMMOGRAPHY

      JAMA, the journal of the American Medical Association
    31. JAMALI FR; RICCI A; DECKERS PJ
      PAGETS-DISEASE OF THE NIPPLE-AREOLA COMPLEX

      The Surgical clinics of North America
    32. LEBOUEDEC G; POMEL C; CHAMUSSY E; FEILLEL V; DELATOUR M; DAUPLAT J
      AXILLARY LYMPH-NODE DISSECTION IN NON-PAL PABLE BREAST CANCERS

      Bulletin du cancer
    33. ROBERTSON JFR
      ESTROGEN-RECEPTOR - A STABLE PHENOTYPE IN BREAST-CANCER

      British Journal of Cancer
    34. THOMAS H; HANBY AM; SMITH RA; HAGGER P; PATEL K; RAIKUNDALIA B; CAMPLEJOHN RS; BALKWILL FR
      AN INBRED COLONY OF ONCOGENE TRANSGENIC MICE - DIVERSITY OF TUMORS AND POTENTIAL AS A THERAPEUTIC MODEL

      British Journal of Cancer
    35. LEONG ASY; LEE AKC
      BIOLOGICAL INDEXES IN THE ASSESSMENT OF BREAST-CANCER

      JCP. Clinical molecular pathology
    36. BROWER ST; AHMED S; TARTTER PI; BLEIWEISS I; AMBERSON JB
      PROGNOSTIC VARIABLES IN INVASIVE BREAST-CANCER - CONTRIBUTION OF COMEDO VERSUS NONCOMEDO IN-SITU COMPONENT

      Annals of surgical oncology
    37. DEPOTTER CR; SCHELFHOUT AM
      THE NEU-PROTEIN AND BREAST-CANCER

      Virchows Archiv
    38. FERNANDO IN; POWLES TJ; DOWSETT M; ASHLEY S; MCROBERT L; TITLEY J; ORMEROD MG; SACKS N; NICOLSON MC; NASH A; FORD HT; ALLAN SM; TROTT PA
      DETERMINING FACTORS WHICH PREDICT RESPONSE TO PRIMARY MEDICAL THERAPYIN BREAST-CANCER USING A SINGLE FINE-NEEDLE ASPIRATE WITH IMMUNOCYTOCHEMICAL STAINING AND FLOW-CYTOMETRY

      Virchows Archiv
    39. SACCOMANDI E; CLOUGH KB; MOSSERI V; VIEHL P; LEGAL M; FOURQUET A; RENOLLEAU C; DURAND JC
      BREAST-CANCER REVEALED BY CLUSTER OF MICR OCALCIFICATIONS WITHOUT PALPABLE MASS - PROGNOSIS AND TREATMENT

      La Presse medicale
    40. CHU FCH
      ORGAN AND FUNCTIONAL PRESERVATION IN THE MANAGEMENT OF BREAST-CANCER

      Cancer investigation
    41. DHINGRA K
      A PHASE-II CHEMOPREVENTION TRIAL DESIGN TO IDENTIFY SURROGATE END-POINT BIOMARKERS IN BREAST-CANCER

      Journal of cellular biochemistry
    42. PAGE DL; JOHNSON JE
      CONTROVERSIES IN THE LOCAL-MANAGEMENT OF INVASIVE AND NONINVASIVE BREAST-CANCER

      Cancer letters
    43. VEGA A; ARRIZABALAGA R; GARIJO F; GUERRA I
      NONPALPABLE BREAST LESION - STEREOTAXIC CORE NEEDLE ASPIRATION BIOPSYWITH A SINGLE-PASS

      Acta radiologica
    44. SCORILAS A; YOTIS J; STRAVOLEMOS K; GOURIOTIS D; KERAMOPOULOS A; AMPELA K; TALIERI M; TRANGAS T
      C-ERBB-2 OVEREXPRESSION MAY BE USED AS AN INDEPENDENT PROGNOSTIC FACTOR FOR BREAST-CANCER PATIENTS

      Anticancer research
    45. IGLEHART JD; KERNS BJ; HUPER G; MARKS JR
      MAINTENANCE OF DNA CONTENT AND ERBB-2 ALTERATIONS IN INTRADUCTAL AND INVASIVE PHASES OF MAMMARY-CANCER

      Breast cancer research and treatment
    46. LIU YL; ELASHRY D; CHEN D; DING IYF; KERN FG
      MCF-7 BREAST-CANCER CELLS OVEREXPRESSING TRANSFECTED C-ERBB-2 HAVE ANIN-VITRO GROWTH ADVANTAGE IN ESTROGEN-DEPLETED CONDITIONS AND REDUCEDESTROGEN-DEPENDENCE AND TAMOXIFEN-SENSITIVITY IN-VIVO

      Breast cancer research and treatment
    47. BENOIT RM; NASLUND MJ
      DETECTION OF LATENT PROSTATE-CANCER FROM ROUTINE SCREENING - COMPARISON WITH BREAST-CANCER SCREENING

      Urology
    48. WELLS CA; MCGREGOR IL; MAKUNURA CN; YEOMANS P; DAVIES JD
      APOCRINE ADENOSIS - A PRECURSOR OF AGGRESSIVE BREAST-CANCER

      Journal of Clinical Pathology
    49. DUFFY MJ
      CAN MOLECULAR MARKERS NOW BE USED FOR EARLY DIAGNOSIS OF MALIGNANCY

      Clinical chemistry
    50. SCHMITT FC; FIGUEIREDO P; LACERDA M
      EXPRESSION OF C-ERB B-2 PROTEIN AND DNA-PLOIDY IN BREAST CARCINOGENESIS

      Archives of pathology and laboratory medicine
    51. CUNY M; SIMONYLAFONTAINE J; ROUANET P; GRENIER J; VALLES H; LAVAILL R; LOUASON G; CAUSSE A; LEQUEUX N; THIERRY C; JEANTEUR P; THEILLET C
      QUANTIFICATION OF ERBB2 PROTEIN EXPRESSION IN BREAST-CANCER - 3 LEVELS OF EXPRESSION DEFINED BY THEIR CLINICOPATHOLOGICAL CORRELATIONS

      Oncology research
    52. TUBIANA M; HOLLAND R; KOPANS DB; KURTZ JM; PETIT JY; RILKE F; SACCHINI V; TORNBERG S
      MANAGEMENT OF NON-PALPABLE AND SMALL LESIONS FOUND IN MASS BREAST SCREENING

      European journal of cancer
    53. RECHT A; VANDONGEN JA; FENTIMAN IS; HOLLAND R; PETERSE JL
      3RD MEETING OF THE DCIS WORKING PARTY OF THE EORTC (FONDAZIONE-CINI, ISOLA-S-GIORGIO, VENEZIA, 28-FEBRUARY-1994) - CONFERENCE REPORT

      European journal of cancer
    54. BRANDTRAUF PW; PINCUS MR; CARNEY WP
      THE C-ERB-2 PROTEIN IN ONCOGENESIS - MOLECULAR-STRUCTURE TO MOLECULAREPIDEMIOLOGY

      Critical reviews in oncogenesis
    55. HAYES DF
      TUMOR-MARKERS FOR BREAST-CANCER - CURRENT UTILITIES AND FUTURE-PROSPECTS

      Hematology/oncology clinics of North America
    56. SILVERSTEIN MJ
      NONINVASIVE BREAST-CANCER - THE DILEMMA OF THE 1990S

      Obstetrics and gynecology clinics of North America
    57. PAGE DL; JENSEN RA
      EVALUATION AND MANAGEMENT OF HIGH-RISK AND PREMALIGNANT LESIONS OF THE BREAST

      World journal of surgery
    58. DEVILEE P; CORNELISSE CJ
      SOMATIC GENETIC CHANGES IN HUMAN BREAST-CANCER

      Biochimica et biophysica acta, CR. Reviews on cancer
    59. ALLRED DC; OCONNELL P; FUQUA SAW; OSBORNE CK
      IMMUNOHISTOCHEMICAL STUDIES OF EARLY BREAST-CANCER EVOLUTION

      Breast cancer research and treatment
    60. BIER B; DOUGLASJONES A; TOTSCH M; DOCKHORNDWORNICZAK B; BOCKER W; JASANI B; SCHMID KW
      IMMUNOHISTOCHEMICAL DEMONSTRATION OF METALLOTHIONEIN IN NORMAL HUMAN BREAST-TISSUE AND BENIGN AND MALIGNANT BREAST-LESIONS

      Breast cancer research and treatment
    61. SMITH KL; ROBBINS PD; DAWKINS HJS; PAPADIMITRIOU JM; REDMOND SL; CARRELLO S; HARVEY JM; STERRETT GF
      C-ERBB-2 AMPLIFICATION IN BREAST-CANCER - DETECTION IN FORMALIN-FIXED, PARAFFIN-EMBEDDED TISSUE BY IN-SITU HYBRIDIZATION

      Human pathology
    62. DEPOTTER CR
      THE NEU-ONCOGENE - MORE THAN A PROGNOSTIC INDICATOR

      Human pathology
    63. REBNER M; RAJU U
      NONINVASIVE BREAST-CANCER

      Radiology
    64. SARKAR FH; VISSCHER DW; CRISSMAN JD
      QUANTITATIVE-ANALYSIS OF HER-2 NEU (ERBB2) GENE-EXPRESSION USING REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION/

      Diagnostic molecular pathology
    65. BIANCHI S; PALLI D; GALLI M; ZAMPI G
      BENIGN BREAST DISEASE AND CANCER RISK

      Critical reviews in oncology/hematology
    66. JARDINES L; WEISS M; FOWBLE B; GREENE M
      NEU(C-ERBB2 HER2) AND THE EPIDERMAL GROWTH-FACTOR RECEPTOR (EGFR) IN BREAST-CANCER/

      Pathobiology
    67. INAJI H; KOYAMA H; MOTOMURA K; NOGUCHI S; MORI Y; KIMURA Y; SUGANO K; OHKURA H
      ERBB-2 PROTEIN-LEVELS IN NIPPLE DISCHARGE - ROLE IN DIAGNOSIS OF EARLY BREAST-CANCER

      Tumor biology
    68. BRADBURY JM; ARNO J; EDWARDS PAW
      INDUCTION OF EPITHELIAL ABNORMALITIES THAT RESEMBLE HUMAN BREAST-LESIONS BY THE EXPRESSION OF THE NEU ERBB-2 ONCOGENE IN RECONSTITUTED MOUSE MAMMARY-GLAND/

      Oncogene
    69. HAYES DF
      TUMOR-MARKERS FOR BREAST-CANCER

      Annals of oncology
    70. POLLER DN; ELLIS IO
      ONCOGENES AND TUMOR MORPHOLOGY PREDICTION

      Modern pathology
    71. ROUANET P; PUJOL H
      CONSERVATIVE SURGERY OF BREAST-CANCER - CHANGES IN IDEAS AND METHODS

      La Presse medicale
    72. KELLOFF GJ; BOONE CW; STEELE VE; CROWELL JA; LUBET R; DOODY LA; GREENWALD P
      DEVELOPMENT OF BREAST-CANCER CHEMOPREVENTIVE DRUGS

      Journal of cellular biochemistry
    73. WILKINSON EJ; HENDRICKS JB
      FINE-NEEDLE ASPIRATION OF THE BREAST FOR DIAGNOSIS OF PREINVASIVE NEOPLASIA

      Journal of cellular biochemistry
    74. ALLRED DC; OCONNELL P; FUQUA SAW
      BIOMARKERS IN EARLY BREAST NEOPLASIA

      Journal of cellular biochemistry
    75. FABIAN CJ; ZALLES C; KAMEL S; MCKITTRICK R; MOORE WP; ZEIGER S; SIMON C; KIMLER B; CRAMER A; GARCIA F; JEWELL W
      BIOMARKER AND CYTOLOGIC ABNORMALITIES IN WOMEN AT HIGH AND LOW-RISK FOR BREAST-CANCER

      Journal of cellular biochemistry
    76. KUSKE RR; BEAN JM; GARCIA DM; PEREZ CA; ANDRIOLE D; PHILPOTT G; FINEBERG B
      BREAST-CONSERVATION THERAPY FOR INTRADUCTAL CARCINOMA OF THE BREAST

      International journal of radiation oncology, biology, physics
    77. VIELH P; VALIDIRE P; KHEIRALLAH S; CAMPANA F; FOURQUET A; DIBONITO L
      PAGETS-DISEASE OF THE NIPPLE WITHOUT CLINICALLY AND RADIOLOGICALLY DETECTABLE BREAST-TUMOR - HISTOCHEMICAL AND IMMUNOHISTOCHEMICAL STUDY OF44 CASES

      Pathology research and practice
    78. DAWKINS HJS; ROBBINS PD; SMITH KL; SAMA M; HARVEY JM; STERRETT GF; PAPADIMITRIOU JM
      WHATS NEW IN BREAST-CANCER - MOLECULAR PERSPECTIVES OF CANCER DEVELOPMENT AND THE ROLE OF THE ONCOGENE C-ERBB-2 IN PROGNOSIS AND DISEASE

      Pathology research and practice
    79. HOLT JT; JENSEN RA; PAGE DL
      HISTOPATHOLOGY - OLD PRINCIPLES AND NEW METHODS

      Cancer surveys
    80. LOBERT PF
      INTEROBSERVER REPRODUCIBILITY

      The American journal of surgical pathology
    81. POLLER DN; ROBERTS EC; BELL JA; ELSTON CW; BLAMEY RW; ELLIS IO
      P53 PROTEIN EXPRESSION IN MAMMARY DUCTAL CARCINOMA INSITU - RELATIONSHIP TO IMMUNOHISTOCHEMICAL EXPRESSION OF ESTROGEN-RECEPTOR AND C-ERB-2PROTEIN

      Human pathology
    82. IKEDA DM; HELVIE MA; FRANK TS; CHAPEL KL; ANDERSSON IT
      PAGET DISEASE OF THE NIPPLE - RADIOLOGIC-PATHOLOGICAL CORRELATION

      Radiology
    83. BOYLE BM
      PREOPERATIVE LOCALIZATION OF BREAST CALCIFICATIONS WITH MAGNIFICATIONTECHNIQUE - ADDITIONAL OBSERVATIONS

      Radiology
    84. KREIPE H; FEIST H; FISCHER L; FELGNER J; HEIDORN K; METTLER L; PARWARESCH R
      AMPLIFICATION OF C-MYC BUT NOT OF C-ERBB-2 IS ASSOCIATED WITH HIGH PROLIFERATIVE CAPACITY IN BREAST-CANCER

      Cancer research
    85. FISHER DE; SCHNITT SJ; CHRISTIAN R; HARRIS JR; HENDERSON IC
      CHEST-WALL RECURRENCE OF DUCTAL CARCINOMA INSITU OF THE BREAST AFTER MASTECTOMY

      Cancer
    86. DIXON JM; SEKAR OR; WALSH J; PATERSON D; ANDERSON TJ
      SPECIMEN-ORIENTATED RADIOGRAPHY HELPS DEFINE EXCISION MARGINS OF MALIGNANT LESIONS DETECTED BY BREAST SCREENING

      British Journal of Surgery
    87. GRIFFIN A; FRAZEE RC
      TREATMENT OF INTRADUCTAL BREAST-CANCER - NONCOMEDO TYPE

      The American surgeon
    88. NIEHANS GA; SINGLETON TP; DYKOSKI D; KIANG DT
      STABILITY OF HER-2 NEU EXPRESSION OVER TIME AND AT MULTIPLE METASTATIC SITES/

      Journal of the National Cancer Institute


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/10/20 alle ore 06:18:12